Atlas Trials

Shu Wang

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Shu Wang

RecordFirmDate
Different Methods of Capecitabine in Patients With Non-PCR After Neoadjuvant Therapy for TNBC (NCT06700382)Shu Wang2019-01-01
Adjuvant Therapy Choice for Non-pCR HER2 Positive Early Breast Cancer After Neoadjuvant Therapy (NCT06693037)Shu Wang2019-01-01
Adjuvant Therapy With Neratinib in HER2 Positive Early Breast Cancer (NCT06693024)Shu Wang2019-01-01
Adjuvant Therapy for Intermediate Risk HER2 Positive, Lymph Node Negative Early Breast Cancer With Chemotherapy Combined Target Therapy (NCT06711068)Shu Wang2019-01-01

Track Shu Wang automatically

Every clearance here is in the API, with alerts when new ones post.